Effect of prior bevacizumab treatment in BRAF V600E-mutant metastatic colorectal cancer: Overall survival with encorafenib plus cetuximab plus /- binimetinib in BEACON CRC

Conference Proceedings

D Aderka, S Kopetz, A Grothey, E Van Cutsem, R Yaeger, H Wasan, T Yoshino, J Desai, F Ciardiello, A Golden, M Edwards, J Tabernero

ANNALS OF ONCOLOGY | ELSEVIER | Published : 2021

Sponsored by Array Biopharma, in collaboration with Merck, ONO Pharmaceutical, and Pierre Fabre. Array Biopharma was acquired by Pfizer in July 2019.